Podcasts about resmed

New York University v. ResMed, Inc.

ResMed beats full‑year earnings and revenue forecasts thanks to a growth in snorers around the world. Figma, the design software, has tripled its market value on its IPO debut in one of the biggest first day pops for a US software company ever. Novo Nordisk, the company behind Ozempic, has seen market value slashed by over €60 billion after investors worry it’s losing the obesity drug race. _ Download the free app (App Store): http://bit.ly/FluxAppStore Download the free app (Google Play): http://bit.ly/FluxappGooglePlay Daily newsletter: https://bit.ly/fluxnewsletter Flux on Instagram: http://bit.ly/fluxinsta Flux on TikTok: https://www.tiktok.com/@flux.finance —- The content in this podcast reflects the views and opinions of the hosts, and is intended for personal and not commercial use. We do not represent or endorse the accuracy or reliability of any opinion, statement or other information provided or distributed in these episodes.__See omnystudio.com/listener for privacy information.

The long-awaited tariff deadline has landed today, and the market has dropped in response. This decline has wiped out the gains from prior in the week, and Laura and Stevie unpack what unfolded with the Trump administration revealing multiple tariffs. Australia’s tariff was low compared to other countries, even New Zealand being given a higher tariff, and Canada has seen a tariff in excess of 30%. The financial sector has declined today weighing on the market, and utilities was the only sector to see gains. Resmed has been one of the winners on the market today, while Star Entertainment hit an all-time low, and Laura and Stevie look to the week ahead. The content in this podcast is prepared, approved and distributed in Australia by Commonwealth Securities Limited ABN 60 067 254 399 AFSL 238814. The information does not take into account your objectives, financial situation or needs. Consider the appropriateness of the information before acting and if necessary, seek appropriate professional advice.See omnystudio.com/listener for privacy information.

This is the Fear and Greed Afternoon Report - everything you need to know about what happened in the markets, economy and world of business today, in just a few minutes. ASX falls Trump tariffs Star crisis ResMed boost Apple surge Find out more: https://fearandgreed.com.au/See omnystudio.com/listener for privacy information.

This is the Fear and Greed Afternoon Report - everything you need to know about what happened in the markets, economy and world of business today, in just a few minutes. ASX falls Trump tariffs Star crisis ResMed boost Apple surge Support the show: http://fearandgreed.com.au/See omnystudio.com/listener for privacy information.

Casiñanos analiza los valores de Indra, Santander, Sarepta Therapeutics,Resmed y Nvidia, entre otros

As July wraps up, all eyes turn to August reporting season, where investors are bracing for modest earnings growth and heightened volatility. Banks, staples and tech stocks face valuation pressure, while retailers and miners contend with weaker demand and rising costs. Expect capital management, cost control and forward guidance to separate the standouts from the strugglers.In this week's wrap, Grady covers:(0:11): the pivot away from the financial sector(1:38): a dive into the technology, retail, healthcare and materials sectors(3:21): key risks to watch out for this reporting season(4:12): how the market performed this week so far(4:47): the most traded stocks and ETFs this week(5:14): economic news items to look out for.

MARKET WRAP: ASX200: down 0.3% to 8,709 GOLD: $3,363 USD/oz BITCOIN: $179,152 CSL advancing 1.5%, to $269.56 Sonic Healthcare and Resmed were also higher. Clarity pharmaceuticals jumped 10% to $4.31 Fortescue's shares rose by 4.3% to $19 after it announced a record volume of iron ore shipments and projected stronger growth. Lynas Rare Earths gained more than 5% to $10.65 Bapcor saw its shares plummet by 28% to $3.66 after it saw weaker sales over the last couple of months. Northern Star Resources dipped by 2.4% Also falling backwards was BHP, Wesfarmers and Macquarie Group AUD/USD: 66.2 US Cents AUD/GBP: 48.9 British Pence AUD/EUR: 56 Euro Cents AUD/JPY: 97 Yen AUD/NZD: $1.09 NZSee omnystudio.com/listener for privacy information.

What happens when you need to rebrand thousands of physical products across global markets? For companies like Logitech and ResMed, changing a logo isn't just about updating a website - it's about retooling manufacturing lines, redesigning packaging for millions of units, and navigating complex regulatory requirements.Join brand leaders Paige Lutter from Logitech and John Barger from ResMed as they share their experiences leading brand strategy for physical product companies. Learn how Logitech solved their global naming challenges with the "Logi" mark, how ResMed approaches branding medical devices, and why both companies treat AI as a utility rather than a branded feature.Key insights include:Managing brand architecture across hardware, software, and digital touchpointsStrategies for implementing brand changes across global product linesThe critical role of executive support in brand transformationBuilding authentic customer connections through physical brand touchpointsBalancing innovation with brand consistency in regulated industriesWhether you're working with physical products or digital experiences, this conversation offers valuable lessons on brand strategy, change management, and the power of patience in building lasting brand value.

Investors weighed inflation data as the consumer price index rose 0.1% in May from April, less than the 0.2% estimate from economists were expecting. Core CPI, which strips out volatile food and energy prices, also increased 0.1%, less than expected. All three major US benchmarks closed lower. The Dow Jones lost 1.1%, the S&P500 lost 0.27%, following a 3- day winning streak, while the Nasdaq closed down 0.5%.European markets were mixed as focus remains on the US - China trade discussions, which occurred this week in London. Germany's DAX is down 0.16%, France's CAC down 0.36%, the FTSE100 was in the green, up 0.13%, while the STOXX600 closed 0.27% lower.Yesterday, the Australian market gained 0.06% by the close, with real estate, energy and materials sectors leading the market's gains. On the other end, information technology was the biggest mover, declining 1.5%, so keep watch of tech stocks today, with the Nasdaq also lower overnightWhat to watch today:The SPI futures are suggesting that our local market will open 0.23% higher this morning, however the futures lost earlier gains this morning, following reports that the US are preparing to partially evacuate the Iraq embassy over regional security.In economic data, consumer inflation expectations will be out at 11:00am this morning.And in commodities:Crude oil has rallied 4.9% trading at US$68.15 per barrel, after President Donald Trump announced a preliminary trade deal with China, raising hopes for stronger energy demand. The agreement includes China supplying rare earth minerals and the US easing restrictions on Chinese students, however final approval is still pending.Gold has gained 1% trading at US$3,363And iron ore is up 0.3% at US$95.78 per tonne.Trading ideas:Bell Potter have maintained their Buy rating on marketing and communications business IVE Group (ASX:IGL) and have increased their price target by 7% to $3.00 as the broker expects a positive trading update and upgrade in FY25 guidance. At the current share price of $2.66 this implies 12.8% share price growth in a year.And Trading Central have identified a bullish signal in ResMed (ASX:RMD) indicating that the stock price may rise from the close of $39.02 to the range of $44.50 to $45.75 over 36 days, according to the standard principles of technical analysis.

US equities closed mixed overnight. The Dow Jones dropped 0.2%, ending at four day winning streak as lower than expected payroll data dragged down sentiment. The S&P500 and the Nasdaq however, both closed in the green, gaining 0.44% and 0.32% respectively.European markets were all in the green with the STOXX600 up 0.47%.Our local market rallied yesterday as the energy sector lead the market with strong gains. Paladin Energy (ASX:PDN) and Mineral Resources (ASX:MIN) were among the top performers.Uranium stocks jumped at the open following news that one of the world's biggest technology companies had stepped up demand for nuclear power.The rise came after Meta overnight signed a 20-year contract to buy 1,121 megawatts from Constellation's nuclear plant, with power supply beginning in 2027. This follows similar deals struck by peers Microsoft, Amazon, and Google parent Alphabet. Nuclear power has emerged as one of the biggest winners from the AI-fuelled surge in electricity needed for data centres. New nuclear reactors are an important source of uranium demand growth. This follows Microsoft's recent deal to fulfil all AI power needs from a US Nuclear power plant.Also yesterday, the GSP growth rate was released. GDP grew at 0.2% in the March quarter following a 0.6% expansion in the prior quarter. Markets were expecting a 0.4% rise so the data out today indicating stalled growth.What to watch today:The Australian market is set to open slightly in the red. The SPI futures are suggesting a 0.1% drop at the open this morning.And in commodities,Crude oil has dropped more than 1% and is trading at US$62.69 per barrel as Saudi Arabia signalled it may push for a large production increase, raising fears of a global oil oversupply.The price of gold has rebounded, advancing 0.6% trading at US$3,373.44 an ounce, and approaching a one-month high, as a series of weak US economic reports renewed concerns over the outlook.And iron ore has jumped more than 1% trading at US$96.26 per tonne. The price is still hovering around eight- month lows as weak economic data from China clouded the metal's demand outlook.Trading ideas:Bell Potter maintain their Buy rating on Elders (ASX:ELD), a leading supplier to fertiliser, agricultural chemicals and animal health products. Their 12- month price target is unchanged at $9.10, and at ELD's current share price of $6.15, this implies 48% share price growth in a year.And Trading Central has identified a bullish signal in ResMed (ASX:RMD) indicating that the stock price may rise from the close of $38.33 to the range of $40.60 - $41.20 over 10 days according to the standard principles of technical analysis.

A credit rating downgrade of the US hurt the Australian share market, but how significant is it for investors? MARKET WRAP: ASX200: up 0.58%, 8343 GOLD: $3,229 US/ounce BITCOIN: $163,965 AUD Technology One, which posted a 33% increase in profit to $81.9 million, shares up 11.3% to $36.76. Wistech rising 2.7% and Life360 up 1.6%. Commbank again hitting fresh highs at $172.43. Wesfarmers, Goodman Group and Telstra all finished higher. Regis Resources down 1.1% to $4.55. Utilities stocks were lower again, with Origin, APA Group and AGL all down. Falling by more than 1% were Northern Star, Resmed and Fisher & Paykel Healthcare. CURRENCY UPDATE: AUD/USD: 64.2 AUD/GBP: 48 pence AUD/EUR: 57 Euro cents AUD/JPY: 93 yen AUD/NZD: 1.09 Dollars See omnystudio.com/listener for privacy information.

For today's episode of Buy or Sell, Adam Keily is joined by William Mumford, Deputy Portfolio Manager at Auscap Asset Management. Here are some of the names Adam and Will cover in today's episode:ResmedCSLNick ScaliCAR groupSeekReliance WorldwideBHPRio TintoCommonwealth BankHomeCo Daily Needs REITAnd if you want to hear more from Adam Keily, make sure you check our Comedian v Economist (Apple | Spotify).In Comedian v Economist, Adam is joined by his brother Thomas, a former RBA economist, to break down the macroeconomic stories of the week.In their most recent episode they spoke about Trump's tariffs on Liberation Day, the latest jobs data, what falling liquor sales can tell us about the economy and the collapse in the market for second-hand Teslas.—------Sign up to our daily news email to get the news moving markets delivered to your inbox at 6am every weekday morning. Short, sharp, to the point, it'll get you up to speed in less than 5 minutes.—------Want more Equity Mates?Listen to our basics-of-investing podcast: Get Started Investing (Apple | Spotify)Watch Equity Mates on YouTubePick up our books: Get Started Investing and Don't Stress, Just InvestFollow us on social media: Instagram, TikTok, & LinkedIn—------In the spirit of reconciliation, Equity Mates Media and the hosts of Equity Mates Investing acknowledge the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander people today. —------Equity Mates Investing is a product of Equity Mates Media. This podcast is intended for education and entertainment purposes. Any advice is general advice only, and has not taken into account your personal financial circumstances, needs or objectives. Before acting on general advice, you should consider if it is relevant to your needs and read the relevant Product Disclosure Statement. And if you are unsure, please speak to a financial professional. Equity Mates Media operates under Australian Financial Services Licence 540697. Hosted on Acast. See acast.com/privacy for more information.

Woodside will kick off a huge new project in the US, but will this lead to better earnings in a sector that’s been under pressure? MARKET WRAP: ASX200: up 0.92% to 8,070 GOLD: $3,354 US/oz BITCOIN: $147,858 AUD Mineral Resources shares closed 13.2% higher to $20.57 after saying it would cut its output of iron ore Boss Energy jumped 14.3% higher to $3.20 Fortescue’s shipping of 46.1 million tonnes of iron ore across the three-month period, sent shares up 5.8% to $16.37. Northern Star downgrading its full-year gold output guidance – with shares down 4.7%. Auckland International Airport shares 4% lower Going backwards were Woolworths, Resmed, and James Hardie CURRENCY UPDATE: AUD/USD: 64.3 US cents AUD/GBP: 47.9 pence AUD/EUR: 56 Euro cents AUD/JPY: 91 Japanese yen AUD/NZD: 1.07 NZ dollars See omnystudio.com/listener for privacy information.

The ASX 200 got another boost before the second long weekend in the row, as the air of volatility starts to subside.See omnystudio.com/listener for privacy information.

"Down cycles are not fun. But they form the basis for enormous future profitability” - Steve SchwarzmanAfter a couple of wild weeks in markets, this week has been a little calmer. The Trump administration has turned its focus to other priorities as the world holds its breathe during the 90-day tariff pause. That is, aside from China, who are pulling out all stops to get the upper hand in this trade war. In today's episode we unpack:How China is using TikTok as a tool in the trade war Meta gets its day in court in its antitrust caseOur views on the latest housing policies by both sides of politics Some of the stocks that are falling into our watch list —------Want to get involved in the podcast? Record a voice note or send us a message —------Keep up with the news moving markets with our daily newsletter and podcast (Apple | Spotify)—------Want more Equity Mates? Across books, podcasts, video and email, however you want to learn about investing - we've got you covered.—------Looking for some of our favourite research tools?Find company information on TIKRScreen the market with GuruFocusResearch reports from Good ResearchTrack your portfolio with Sharesight—------In the spirit of reconciliation, Equity Mates Media and the hosts of Equity Mates Investing acknowledge the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander people today. —------Equity Mates Investing is a product of Equity Mates Media. This podcast is intended for education and entertainment purposes. Any advice is general advice only, and has not taken into account your personal financial circumstances, needs or objectives. Before acting on general advice, you should consider if it is relevant to your needs and read the relevant Product Disclosure Statement. And if you are unsure, please speak to a financial professional. Equity Mates Media operates under Australian Financial Services Licence 540697. Hosted on Acast. See acast.com/privacy for more information.

Collins Foods will offload Taco Bell, but can it be blamed on the rise of Guzman y Gomez? MARKET WRAP: ASX200: up 0.17% to 7,761 GOLD: $3,246 US/oz BITCOIN: $135,130 AUD Collins shares down almost 8% to $8.00, while rival GYG falling 0.3% to $33.40. Evolution Mining hit a record high today up just under 4% to $8.21 CSL had a healthy day up 2.6% to $244.10 but still well off its 52 week high of $313.55. Resmed also a touch higher The big 4 banks were all higher led by Westpac up 0.8% to $30.76. BHP and RIO both up with Fortescue the standout up 0.8% to $15.32 Treasury Wine stocks fell 3.4% to $8.30. Wesfarmers marginally weaker to $74.21 Aristocrat Leisure also fell 1.2% to $62.21. Star Entertainment released its half year results, posting a loss of $300 million for the half. CURRENCY UPDATE: AUD/USD: 63.6 US cents AUD/GBP: 48.1 pence AUD/EUR: 56 Euro cents AUD/JPY: 91 Japanese yen AUD/NZD: 1.07 NZ dollars See omnystudio.com/listener for privacy information.

A deal for De Grey mining looks even certain of getting done, at a time where the gold price is surging to even higher prices. MARKET WRAP: ASX200: up 1.34%, 7,748 GOLD: $3,242 US/oz BITCOIN: $133,593 AUD Neuren Pharmaceuticals rising by 21% to $11.13 as they got FDA approval on a trial to treat childhood disorders. DroneShield stock jumped 16% to $1.03 after securing $32 million in contracts with an Asian military ally. Gold stocks shined following a long term broker upgrade on the gold price. Newmont jumped more than 4% to $87.04. De Grey Mining also got a boost of 1.6% after Gold Road Resources, a minority investor, supported the $5 billion takeover bid from Northern Star. Resmed closed down just under 2% to $33.61 A2 Milk shares fell by 3% to $8.06 Telstra which is still within a few cents of its 52 week high fell just 2 cents to $4.43 CURRENCY UPDATE: AUD/USD: 63.3 US cents AUD/GBP: 48.0 pence AUD/EUR: 58 Euro cents AUD/JPY: 90 Japanese yen AUD/NZD: 1.07 NZ dollars See omnystudio.com/listener for privacy information.

“Are you okay?” That was the question Emma Fisher got from her mum after the ASX plunged more than 6% in a single day. For Fisher, it was a soft signal that the worst of the panic may be behind us. In this episode of The Rules of Investing, Emma shares why sharp sell-offs are the new normal, the two market “buckets” she's buying from, and how she's funding new ideas. Last time she was on the podcast, Emma tipped ResMed at $22. This time, she's back with a fresh idea she's backing for the next 5 years. _____________________ Thanks to our Sponsor AlphaSense This latest episode is brought to you by AlphaSense. See what AlphaSense can do for your investment research—visit alpha-sense.com/livewire to get started.

Dear Listeners, Welcome back to the Primary Medicine Podcast! Today's guest is Ron Richard, a true healthcare innovator with over 35 years of experience in respiratory, pulmonary, and sleep medicine. From launching over 40 medical products and holding 15 patents to working with industry leaders like ResMed and Qualcomm, Ron has helped shape the future […] The post Episode 105: From Bedside to Breakthrough: Ron Richard on Innovation and Invention appeared first on Primary Medicine Podcast.

MARKET WRAP: ASX200: up 0.83%, 7,854 GOLD: $2,997 US/oz BITCOIN: $131,789 AUD BHP gained 2.4%, Fortescue rising 4.2%, and Rio Tinto up 1.8%. Mineral Resources was another miner getting a bump after a UBS upgrade of the company saw it gain more than 11% to $24.49 Confirmation of a merger between Spartan Resources and Ramelius Resources sent Spartan 9.1% higher – Ramelius going the other way by 0.9% The oil price pushing back over US $71 a barrel helped Woodside gain 1.9%. Most of the big banks finished higher, but NAB fell 0.2% to $33.24 after it announced changes to its executive team. Losses were felt in the Healthcare sector.. CSL dropped 0.9% and Resmed fell 1.3%. Telstra, Woolworths and Coles all down CURRENCY UPDATE: AUD/USD: 63.37 US cents AUD/GBP: 48.9 pence AUD/EUR: 58 Euro cents AUD/JPY: 94 Japanese yen AUD/NZD: 1.09 NZ dollars See omnystudio.com/listener for privacy information.

Donald Trump’s tariff plans have sent fear through currency markets, so how much will it affect Australia? MARKET WRAP: ASX200: down 0.91%, 7,890 GOLD: $2,904 US/oz BITCOIN: $127,794 AUD The local ASX couldn’t hold back the tide, dropping another 0.9% or 72 points to 7890 – a low not seen since mid-August last year. Only defensive areas like Utilities, Energy & Consumer Staples in positive territory. Life 360, which is also listed on Wall Street, tumbled 8.7%, Xero was down 5.1%, Technology One suffered by 5.7% and Wisetech shed 1.9%. A block trade by investors of Nickel Industries was the reason it fell almost 20% to 60 cents a piece. Ramelius Resources will spend almost $100 million on upgrades to its Mt Magnet mill, seeing shares down 17.2% to $2.31. Commonwealth Bank – another drop of 0.8% sending shares down to $146.92. Westpac, NAB and ANZ bucked the market trend to finish ahead. Utility stocks gained ground, with Origin up 1.4% and APA Group up 1.9% BHP up 1.2%, Woodside stronger by 1.2% and Resmed surging 3%. CURRENCY UPDATE: AUD/USD: 62.81 US cents AUD/GBP: 48.7 pence AUD/EUR: 57 Euro cents AUD/JPY: 92 Japanese yen AUD/NZD: 1.10 NZ dollars See omnystudio.com/listener for privacy information.

BHP has made yet another move to expand into copper, in what could be a hedge against iron ore price fluctuations. MARKET WRAP: ASX200: up 0.18%, 7,962 GOLD: $2,920 US/oz BITCOIN: $130,189 AUD Woodside gained 1.9%, Yancoal was up 2.5% and Whitehaven rose 3.5%. BHP looks headed to Africa to search for copper, signing a deal with an explorer & development company and gaining half a percent. Gains of more than 1% for Computureshare, QBE and Resmed. A mixed day for the banks saw Commbank, NAB and Westpac all finishing lower. Johns Lyng group will be removed from the ASX 200 index, sending its shares down another 12.5% to $2.45. And Star Entertainment is still not trading, but is considering a rescue offer from a US-based casino Group. CURRENCY UPDATE: AUD/USD: 63.17 US cents AUD/GBP: 48.9 pence AUD/EUR: 58 Euro cents AUD/JPY: 93 Japanese yen AUD/NZD: 1.10 NZ dollars See omnystudio.com/listener for privacy information.

With Donald Trump’s new tariff program hitting China hard, will Australia’s iron ore miners suffer in the process? MARKET WRAP: ASX200: down 0.58% to 8,198 GOLD: $2,903 US/oz BITCOIN: $134,474 AUD An oil price resulted in a 3.2% fall across Energy stocks, with Woodside falling over 3%, Santos was down 4.7%, and Ampol shed almost 2%. The threat of Cyclone Alfred saw insurers Suncorp and QBE both down 2%, while IAG was off by 1.7%. Origin dropped 4.2% and Nick Scali fell 3.9% as both traded ex-dividend. Qantas made it over $10 for the first time, rising 2.1% to $10.20. Health Care’s good day was led by CSL rising 1% and Resmed lifting 0.9%. Gains of more than 1% for Transurban, Evolution Mining, and Mirvac. CURRENCY UPDATE: AUD/USD: 62.06 US cents AUD/GBP: 48.9 pence AUD/EUR: 59 Euro cents AUD/JPY: 92 Japanese yen AUD/NZD: 1.10 NZ dollars See omnystudio.com/listener for privacy information.

From Pickwickian Syndrome to Sleep Disordered Breathing, Obstructive Sleep Apnea, OSA, and everything in between. Well it all started with a vacuum cleaner!Meet Dr Peter Farrell, founder and former CEO of Resmed; the little company we all know very well! Dr Farrell tells about his time in university in Australia, then at MIT, and finally meeting with Dr Collin Sullivan to develop the first commercially available CPAP machine. Learn the fascinating origin story of the CPAP and how Resmed grew from 9 people to the 10,000 person multinational company we know today. For more information vistit resmed.comA huge thanks to our sponsors:Medbridge Healthcare: For Job Opportunities with MedBridge Healthcare visit: https://medbridgehealthcare.com/careers/Don't forget to Like, Share, Comment, and Subscribe!Learn more about the show at https://www.sleeptechtalk.com/thetechroomCredits:Audio/ Video: Diego R Mannikarote; Music: Pierce G MannikaroteHosts: J. Emerson Kerr, Robert Miller, Gerald George MannikaroteCopyright: ⓒ 2025 SleepTech Talk ProductionsEpisode 94Sleep apnea, obstructive sleep apnea, oral sleep appliance, inspire, surgery, sleep surgery, CPAP

Buy or Sell with Adam Keily is back for 2025! In our first episode, Adam is joined by Adam Dawes, Senior Investment Adviser at Shaw & Partners. Tune in to hear Adam's take on the following companies:IFL PLS BWP AMC EIQ XROJBH RMDEVNALL—------Want to get involved in the podcast? Record a voice note or send us a message on our website and we'll play it on the podcast.—------Sign up to our daily news email to get the news moving markets delivered to your inbox at 6am every weekday morning. Short, sharp, to the point, it'll get you up to speed in less than 5 minutes.—------Want more Equity Mates?Listen to our basics-of-investing podcast: Get Started Investing (Apple | Spotify)Watch Equity Mates on YouTubePick up our books: Get Started Investing and Don't Stress, Just InvestFollow us on social media: Instagram, TikTok, & LinkedIn—------In the spirit of reconciliation, Equity Mates Media and the hosts of Equity Mates Investing acknowledge the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander people today. —------Equity Mates Investing is a product of Equity Mates Media. This podcast is intended for education and entertainment purposes. Any advice is general advice only, and has not taken into account your personal financial circumstances, needs or objectives. Before acting on general advice, you should consider if it is relevant to your needs and read the relevant Product Disclosure Statement. And if you are unsure, please speak to a financial professional. Equity Mates Media operates under Australian Financial Services Licence 540697. Hosted on Acast. See acast.com/privacy for more information.

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi talks with Dr. Maria Artunduaga, the founder and CEO of Samay, a startup that's using acoustic energy to get a clearer picture of the lung's performance. Family tragedy and professional frustration set Dr. Artunduaga on a course that won MedTech Innovator's Grand Prize. She has the giant check to prove it. This episode was sponsored by DeviceTalks Boston. You can register at Boston.DeviceTalks.com. Rachel Robinson, COO of MassMEDIC, joins us on the Newmarker's Newsmakers. Before we hit the news of the week, Robinson gave a preview of the upcoming MassMEDIC's Symposium & Gala on March 6. Go to MassMEDIC.com for more information. MassDevice Executive Editor Chris Newmaker then delivers news on - Boston Scientific, ResMed, Globus Medical, BD and Baxter. Hilarity ensues. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don't miss a future episode.

Trump’s tariffs tanked global markets, but could there be some ASX-listed entities that benefit from the global trade fall out. MARKET WRAP: ASX200: down 1.79%, 8,379 GOLD: $2,819 US/oz BITCOIN: $155,130 AUD Fisher & Paykel Healthcare said its cost pressures would increase from the Mexican tariffs, sending its shares down 7.4% to $31.80 CSL was down 1.8%, Pro Medicus fell 3% and Resmed dropped 3.1%. A reduction in full-year guidance from Westgold after slower-than-expected progress on its mines saw its shares losing 12.4% to $2.26 Fortescue down 4.4%, NAB shed 2.3% and Wesfarmers dropped 1.9%. KMD Brands rose 4.1% to 38 cents a share Regis Resources established a $300 million credit facility, sending its shares almost 2% higher. Telstra, Yancoal, and Seek swam against the tide to finish higher. CURRENCY UPDATE: AUD/USD: 61.40 US cents AUD/GBP: 49.9 pence AUD/EUR: 59 Euro cents AUD/JPY: 95 Japanese yen AUD/NZD: 1.10 NZ dollars See omnystudio.com/listener for privacy information.

On episode 502 of The Nurse Keith Show nursing and healthcare career podcast, Keith interviews Ron Richard, BBA, a medical device consultant, inventor, and author with a long track record of successfully developing and launching dozens of medical products. In the course of their conversation, Keith and Ron discuss how nurses and other healthcare professionals can leverage their expertise as consultants and inventors in the sphere of medical device development. Mr. Richard has been employed in the medical industry for over thirty-five years and has extensive knowledge and experience in respiratory, pulmonary and sleep medicine. He began his medical career working in a respiratory department at a large teaching hospital in the Midwest. Upon leaving the medical center, Ron became involved in owning and operating home care companies, sleep laboratories, manufacturers and distribution businesses. In addition to these experiences he was instrumental in developing and designing several products used in the treatment and diagnosis of chronic health care conditions. In the course of his career, Mr. Richard has launched over 40 major products resulting in sales over $1B. He has held senior level positions with Nellcor Puritan Bennett, Thermo Electron, ResMed, Qualcomm, SeQual Technologies and several other companies in sleep and respiratory care sectors. Having graduated from Baker University with a degree in Business Administration, he also holds certificates in respiratory care and emergency medicine, and has been awarded 15 patents and multiple industry awards due to his focus and dedication to improving health care outcomes. Mr. Richard also enjoys writing music and performing live concerts around the country and has played over 500 shows over the past 10 years. In 2021 he published a new book, Someday is Today! Get your Ideas out of your coffee cup and on the market, containing experiential information pertaining to FDA, patents, raising capital, team formation, sales, marketing and product launches. Connect with Ron Richard: InventingStartsToday.com LinkedIn Someday is Today on Amazon Contact Nurse Keith about holistic career coaching to elevate your nursing and healthcare career at NurseKeith.com. Keith also offers services as a motivational and keynote speaker and freelance nurse writer. You can always find Keith on LinkedIn. Are you looking for a novel way to empower your career and move forward in life? Keith's wife, Shada McKenzie, is a gifted astrologer and reader of the tarot who combines ancient and modern techniques to provide valuable insights into your motivations, aspirations, and life trajectory, and she offers listeners of The Nurse Keith Show a 10% discount on their first consultation. Contact Shada at TheCircelandtheDot.com or shada@thecircleandthedot.com.

In this episode of Investor Connect, we dive into two distinct yet promising sectors: medical diagnostics and sleep technology. Michael Cormack from Corwin Medical elaborates on the company's efforts to tackle peripheral artery disease (PAD) through innovative diagnostic systems that leverage multi-element ultrasound arrays and AI-based algorithms. He elaborates on the severe impact of PAD, its high mortality rate, and the cumbersome nature of current diagnostic tools like the Doppler Pencil Probe. Michael outlines their unique Ultrasense system, which promises faster, more accurate diagnostics, detailing a robust business model and strong leadership geared towards high-margin revenue and strategic industry partnerships with entities like Medtronic and Philips. He highlights the company's commercialization timeline and financial trajectory towards profitability by 2026, supported by a strong patent portfolio and seed funding efforts. The compelling patient stories and strong market need underscore the critical importance of their work in early PAD detection and intervention.  Following this, we turn our focus to SleepScore Labs with Colin Lawlor, who shares his journey from ResMed to founding an organization dedicated to leveraging AI and data for improving consumer sleep. Recognizing sleep's critical role in overall health, Colin outlines how SleepScore Labs utilizes proprietary sleep data and intervention studies to provide companies with actionable insights and personalized coaching solutions. The importance of sleep for mitigating chronic diseases and optimizing wellness drives their market opportunity, particularly through B2B2C models with partners like Mattress Firm and Terabody. By highlighting their success in Germany, where their platform is reimbursed by insurance without a doctor's prescription, Colin emphasizes the robust, scalable business model ready to capitalize on the growing demand for sleep solutions.  The episode closes with both Cormack and Lawlor discussing their exit strategies and potential for partnerships with industry giants, illustrating the potential for innovation in medical diagnostics and sleep technology. The detailed exploration into these fields gives investors and entrepreneurs critical insights into the paths to market success and the transformative potential of these cutting-edge technologies. Team and Funding 30:14 Q&A and Conclusion

In our final 2024 episode of the DeviceTalks Weekly podcast, ResMed CEO Mick Farrell shares the company's strategy for reaching the billions of people who need help sleeping, breathing and remaining healthy. He talks with Host Tom Salemi about the company's connectivity capabilities, response to wearable technology, and its take on a rival's recall. This episode is sponsored by Aptyx. Go to www.Aptyx.com to learn more. We'll also bring you the Newsmakers of 2024 brought to you by DeviceTalks Managing Editor Kayleen Brown as well as our Editorial Team - Editor Chris Newmarker, Senior Editor Danielle Kirsh, Associate Editor Sean Whooley, and Jim Hammerand, managing editor of Medical Design and Outsourcing. Thank you for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast player.

There has been a lot of VR news lately. We'll get caught up on the world of Nate's Apple Vision Pro, Dave's Meta Quest, and Samsung is getting into the game with Apple. Are you on the VR bandwagon yet? Plus, we've got all of the other segments, tech news, tips, and picks to help you tech better! Watch on YouTube! INTRO (00:00) Amazingly Awkward Christmas Playlist (04:10) MAIN TOPIC: Apple, Meta, Google VR News (10:05) Tim Cook defends Vision Pro's sales performance with three words Popular Science Innovation of the Year - Apple Vision Pro Simply Piano now lets you learn to play through Apple Vision Pro — no keyboard required ResMed debuts ergonomic head strap for Vision Pro Blackmagic debuts $30,000 3D camera for capturing video for Vision Pro Apple Vision Pro has completely changed how Porsche unveils sports cars in two ways Latest Meta Quest 3 update includes a major visual overhaul, and improved PCVR This Vision Pro clone from Samsung and Google is good news for Apple users DAVE'S PRO-TIP OF THE WEEK:  Return of the volume slider on the Lock Screen (28:30) JUST THE HEADLINES: (34:00) Scrabble star wins Spanish world title – despite not speaking Spanish X gains a faster Grok model and a new ‘Grok button' Startup will brick $800 emotional support robot for kids without refunds LG stops making Blu-ray players Australia struggling with oversupply of solar power Grubhub just sold for $650 million. Four years ago it was worth $7.3 billion YouTube TV Hikes Price $10 to $82.99 TAKES Tips pour in over 5,000 drone sightings. Reason to worry? Government says no (40:20) Artificial intelligence is helping archaeologists unlock Earth's oldest secrets (44:00) T-Mobile opens registration for Starlink direct-to-cell satellite service beta launch (45:55) An official statement from Peak Design regarding privacy (46:55) BONUS ODD TAKE: Open the microwave door game (49:15) PICKS OF THE WEEK: Dave: Bambu Lab A1 Combo (52:15) Nate: 32 Inch Webcam Stand Camera Mount, Upgraded Thick Base Flexible Gooseneck Camera Stand Desk Webcam Mount Clamp for Logitech Webcam C930e C930 C920 C922x C922 Brio 4K C925e C615, Gopro Hero 8 7 6 5 4 (01:00:25) RAMAZON PURCHASE - Giveaway! (01:03:05) Find us elsewhere: https://notpicks.com - Find links to previous picks of the week https://www.notnerd.com - All things Notnerd

The merger between Chemist Warehouse and Sigma looks closer than ever after the companies gave an update to the market today. MARKET WRAP: ASX200: down 0.75%, 8,193 GOLD: $2,612 US/oz BITCOIN: $134,135 AUD Nine of the eleven sectors were in the red, with tech stocks again the biggest loser Wisetech slid 3% to $121.79, and Xero down 1.4% to $168.62. South32 dropping 4.4% to $3.52 after saying escalating problems in Mozambique had affected transport to its operations. ANZ, Rio Tinto and Santos were all down by more than 1%. Higher real estate stocks were led by Goodman, up 1.7% and Stockland, up 2.2%. While also lifting were Wesfarmers, Pro Medicus and Resmed. CURRENCY UPDATE: AUD/USD: 64.74 US cents AUD/GBP: 49.9 pence AUD/EUR: 60 Euro cents AUD/JPY: 96 Japanese yen AUD/NZD: 1.10 NZ dollars See omnystudio.com/listener for privacy information.

ANZ will bring in an ex-HSBC Portuguese banker to fill their vacant CEO role, but will investors warm to the appointment? MARKET WRAP: ASX200: up 0.03%, 8,423 GOLD: $2,671 US/oz BITCOIN: $155,084 AUD ANZ CEO Shayne Elliott stepping down after nine years in the role; shares down 3.6% to $30.03. GQG Partners gained 6.3% to $2.21 after reporting higher funds under management through November. Discretionary stocks got a boost, with Breville up 2.9%, and GYG lifting 1.1%. Also up over 1% was Commbank and Resmed. A fall in the oil price didn't help the Energy sector, with Woodside down 1.1% and Santos dropping 0.8%. Life360 dropped 8.3% to $24.03 as its listing on the US indices faced some challenges. BHP, Fortescue and Rio Tinto all down.   CURRENCY UPDATE: AUD/USD: 64.15 US cents AUD/GBP: 50.30 pence AUD/EUR: 60.8 Euro cents AUD/JPY: 96 Japanese yen AUD/NZD: 1.10 NZ dollars See omnystudio.com/listener for privacy information.

ResMed (RMD) CEO Mick Farrell joins Morning Trade Live to discuss the company's latest earnings beat. ResMed primarily focuses on sleep apnea and COPD. He talks about GLP-1 medications and consumer tech offering medical monitoring like the Apple (AAPL) Watch. He discusses the customer base for ResMed and its hardware vs software businesses. ======== Schwab Network ======== Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe Download the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185 Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7 Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watch Watch on Vizio - https://www.vizio.com/en/watchfreeplus-explore Watch on DistroTV - https://www.distro.tv/live/schwab-network/ Follow us on X – https://twitter.com/schwabnetwork Follow us on Facebook – https://www.facebook.com/schwabnetwork Follow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

The Qantas board has avoided a second strike on its remuneration report as its share price hit a record so Mahnaz Angury spoke with Upstream Aviation Analyst Tim Collins to find out if its reputation is being repaired; Rhayna Bosch discusses the future of AI and the implication of GLP-1 drugs like Ozempic with ResMed CEO Michael Farrell; and SBS Finance Editor Ricardo Gonçalves looks through the day's market news with Isaac Poole from Oreana Group.

ResMed's leadership in sleep apnea stems from the combination of its digital-health ecosystem and new hardware to pair with smartwatches and wearables, CEO Mick Farrell tells Bloomberg Intelligence. The mix creates an end-to-end solution for diagnosis of sleep apnea, accelerated patient setup and resupply and proper data management to increase the adherence rate to 80%, he says. In this Vanguards of Health Care episode, Farrell sits down with BI analyst Matt Henriksson for an in-depth interview about how the company started as a spinoff from Baxter to become the market leader in sleep-apnea treatments. Those include novel technologies such as the AirSense 11 continuous positive airway pressure (CPAP) device and n30i mask. Farrell believes the rise of GLPs will have a “Botox effect” on sleep apnea, as patients become more aware of the disease and doctors use all available tools, including ResMed's CPAP devices, to treat it.See omnystudio.com/listener for privacy information.

In this episode of the 10x Growth Strategies podcast, host Aarti Vijayaragavan converses with Urvashi Tyagi, CTO of Resmed, focusing on the pivotal role of Emotional Intelligence (EQ) in personal and professional growth. This conversation features the book " Emotional Intelligence" by Dr.Travis Bradberry and Dr.Jean Greaves. They explore how EQ helps in self-management and introspection, and its influence in organizational leadership. Urvashi shares personal anecdotes, illustrating the impact of EQ on her career and personal life, while highlighting vital skills like self-awareness, social awareness, and relationship management. The discussion touches upon Urvashi's learnings from the book 'Emotional Intelligence' and its companion read 'Power' by Jeffrey Pfeffer, emphasizing that empathetic leadership fosters influence and empowerment.  Topics: 00:00 Introduction to Emotional Intelligence 01:23 Meet Urvashi Thyagi: A Leader in Digital Transformation 02:21 The Impact of Emotional Intelligence on Personal and Professional Life 02:48 Understanding and Developing EQ Skills 04:55 The Role of Self-Awareness in Emotional Intelligence 15:21 Strategies for Self-Management and Introspection 19:15 The Power of Influence and Empathetic Leadership 25:30 Building and Maintaining Relationships 30:37 Key Takeaways and Final Thoughts

In this week's episode of the DeviceTalks Weekly Podcast, Nick Damiano, co-founder and CEO of Andromeda Surgical, previews his talk at DeviceTalks West by introducing listeners to the potential of autonomous surgery. Still early goings on, but Damiano paints and interesting picture of the future. If you want to see the future register at West.DeviceTalks.com. Speaking of the future, Host Tom Salemi speaks with Brody Galloway, a young MedTech professional who has turned his life's healthcare experiences into a love of the industry and a drive to help. Anyone who wants to help should go to EnvisionMedtech.org. MassDevice Editor Chris Newmarker returns with his Newmarker's Newsmakers – Surgical Robotics, Medtronic, ResMed, Layoffs and, of course, Baxter Healthcare. Thanks for listening to the DeviceTalks Podcast Network. Subscribe to the DeviceTalks Podcast Network so you don't miss an episode of this or other industry-leading podcasts.

Today's guest is Urvashi Tiyagi, Advisor and Former CTO at ResMed. Urvashi joins us on today's podcast with Emerj Senior Matthew DeMello to discuss the unique challenges healthcare leaders face in driving software development efficiencies for medical devices and customer-facing mobile applications. As the med tech industry strives to balance innovation with regulatory compliance, many companies find themselves navigating complex approval processes that can delay product launches and stifle progress. This episode is sponsored by Pieces. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

In der heutigen Folge von „Alles auf Aktien“ sprechen die Finanzjournalisten Daniel Eckert und Holger Zschäpitz über eine Spielverderberin bei Adidas, eine Hedgefonds-Attacke bei Ubisoft und den Ritterschlag von Palantir. Außerdem geht es um Sartorius Vz., Alphabet (Google), AT&T, Microsoft, IBM, Oracle, Amazon, ARM Holding, ResMed, Invesco EQQQ Nasdaq-100 thesaurierend (WKN: A2N6RV), WisdomTree NASDAQ 100 3x Daily Leveraged ETF (WKN: A3GL7E). Wir freuen uns an Feedback über aaa@welt.de. Ab sofort gibt es noch mehr "Alles auf Aktien" bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter.[ Hier bei WELT.](https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html.) Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem bei WELT: Im werktäglichen Podcast „Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? [**Hier findest du alle Infos & Rabatte!**](https://linktr.ee/alles_auf_aktien) Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Justin Nielsen and Alissa Coram walk through this week's technical action and stocks to watch in the Friday extended version of Stock Market Today.

Anna Bergevin, Sr. Product Manager at ResMed, brings her honest no-bs takes about data product management work and who should be doing it. We will discuss her path into data product management and how she is using AI to be productive and try new things!

Anna Bergevin, Sr. Product Manager at ResMed, brings her honest no-bs takes about data product management work and who should be doing it. We will discuss her path into data product management and how she is using AI to be productive and try new things!

Listen & subscribe on Apple, Google, Spotify, and other platforms. Welcome everyone to the weekly San Diego Tech News by Neal Bloom and Fred Grier from Fresh Brewed Tech. I'm Neal Bloom from Fresh Brewed Tech, the Tacos and Tech Podcast, and Interlock Capital. I'm Fred Grier, journalist and author of The Business of San Diego substack. I wrote about the tech industry for the San Diego Business Journal for two years. I covered the ins-and-outs of the startup world for much of that time, breaking news on IPOs, fundraising rounds, and M&A. Promote the show:  Before we dive in, we wanted to ask our listeners and SD Tech fans to help us grow the show, leave a review and share with one other person who should be more plugged in with the SD Tech Scene. Thank you for the support and for helping us build the San Diego Startup Community. 8/14 Avalon BioVentures Startup Acquired for 1.3B Earnings Season Read Out Qualcomm up 20% Resmed up 32% Sempra up 5%   San Diego Angel Conference moving to SDSU TuSimple visit EvoNexus Partners with Healthcare Companies to Accelerate Startups Metropolis IQ launches    Events – For full list – check The Social Coyote Carlsbad Life in Action Cleantech debrief NuFund Summer Social debrief CEO Retreat in Valle de Guadalupe by SVB, DLA Piper, and  Aug 21 - North County SD Startup Mixer Aug 22 - EDC Summer BashAug 26 - Carlsbad Life Science Gathering at Thermo Fisher Sept 6 - SD Founders Hike Sept 12 - Wharton Biotech panel Sept 16 - Evonexus Demo Day Sept 19 - Dev & Data Night x CTO Talks at Seismic Sept 23 - Pitch Deck Workshop for SD Startups Sept 23 - Carlsbad Tech Gathering at Shipcalm Sept 24 - Connect Innovation Day Oct 4 - SD Founders Hike Oct 20-22 - Stocktoberfest Oct 21-25 - San Diego Startup Week

In der heutigen Folge von „Alles auf Aktien“ sprechen die Finanzjournalisten Anja Ettel und Philipp Vetter über zwei Nachrichten aus der Rüstungs-Branche, den Chipotle-Boom bei Starbucks und den neuen Mut der Regulatoren im Umgang mit den Tech-Giganten. Außerdem geht es um ResMed, Eli Lilly, Novo Nordisk, Burger King, Coca Cola, Starbucks, Chipotle Mexican Grill, Rheinmetall, Renk, Volkswagen, Google, Meta, Bytedance, Alphabet, Amazon und Apple. Wir freuen uns an Feedback über aaa@welt.de. Ab sofort gibt es noch mehr "Alles auf Aktien" bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem bei WELT: Im werktäglichen Podcast „Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

In this episode of DeviceTalks Weekly Podcast, Host Tom Salemi interviews Jim Hollingshead, PhD, the CEO of Insulet. Hollingshead had the unenviable job of taking over for CEO Shacey Petrovic when she left the insulin-delivery company two years ago. Hollingshead previously had helped ResMed develop its industry-leading connectivity/cloud strategy. In this conversation you'll hear about his journey and what steps Insulet has taken to build share in the Type 1 and Type 2 diabetes markets MassDevice Editor Chris Newmaker returns with his newsmakers - Asensus Surgical, Tandem, Stryker, Perceptive, and BiVacor. This episode is sponsored by DeviceTalks West. Register to attend at West.DeviceTalks.com Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don't miss a future episode.

Medical device maker Resmed reports its earnings and signals potential partnerships with big tech. Rhayna Bosch talks to ResMed CEO Mick Farrell. Meanwhile – global share markets come crashing down – and Mahjabeen Zaman, the head of FX Researxch at ANZ Babnk says the ASX200 is clocking its WORST single trading day in 16 months.

ResMed has had the market on sleep apnea cornered for a while, but new weight-loss drugs might be creeping in. We look at what could change based on recent studies and some other businesses that have established lifelong customers. (00:21) Bill Barker and Dylan Lewis discuss: - How weight-loss drugs like Eli Lilly's Zepbound might be coming for ResMed and the sleep apnea market. - RXO take a bigger piece of the brokered transportation market, scooping up Coyote Logistics from UPS. - Target and Shopify linking up for a win-win partnership. (13:02) Tim Beyers and Ricky Mulvey discuss the value of lifetime-customer relationships, why they're huge for the likes of Apple, and Costco, and one lesser-known name that may have one too. Companies discussed: LLY, NVO, RMD, SPOT, AAPL, SNOW Host: Dylan Lewis Guests: Tim Beyers, Tim Beyers, Ricky Mulvey Producer: Ricky Mulvey Engineers: Dan Boyd Learn more about your ad choices. Visit megaphone.fm/adchoices

Want to shift from managing people to building a culture & a team?In this episode of The Business Ownership Podcast I interviewed Jason Scott.J. Scott, a talentless, real-life anti-hero who doesn't just talk the talk, he walks the walk. Growing up in the streets of Los Angeles with less-than-ideal parents, J. learned early on that actions speak louder than words.J. Scott is the epitome of the anti-thought leader, proving that leadership isn't about being the most talented or successful person on the team. It's about helping your team members define and deliver success. If you surround yourself with talented people and inspire them to reach for THEIR potential, the leader doesn't need to be talented. They just have to play for the team. J. Scott is a regular guy who's proven that actions speak louder than words.Jason has spent over 20 years leading global transformational efforts for DirecTV, Trader Joe's, Blizzard Entertainment, RIOT Games, Sony Pictures, ResMed, AAG, Universal Music Group, Remitly, and others. He is the author of two Amazon-bestselling books “It's Never Just Business: It's About People” and “The Irreverent Guide to Project Management, An Agile Approach to Enterprise Project Management.” Jason is a sought-after keynote speaker, with 5-star reviews for his unique, people-centric, and outcome-obsessed approach to change that has generated breakthrough results and created meaningful jobs. His passion to mentor and training a new generation of leaders led him to start the Transformational Leadership Academy where he leads a 14-week certification program. Learn how to build a high-performing team. Check this out!Show Links:Jason Scott LinkedIn: https://www.linkedin.com/in/jasonscottJason Scott Website: https://www.jasonscottleadership.com/120VC Website: https://www.120vc.com/120VC YouTube Channel: https://www.youtube.com/channel/UCTqPCasdYzfsJ7nV61KWSqQBook a call with Michelle: https://www.AwarenessStrategies.com/m30Join our Facebook group for business owners to get help or help other business owners! The Business Ownership Group - Secrets to Scaling: https://www.facebook.com/groups/businessownershipsecretstoscalingLooking to scale your business? Get free gifts here to help you on your way: https://www.awarenessstrategies.com/